25 XP   0   0   10

Shandong Xinhua Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Shandong Xinhua Pharmaceutical Co Ltd together

PenkeI guess you are interested in Shandong Xinhua Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Shandong Xinhua Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Shandong Xinhua Pharmaceutical Co Ltd

I send you an email if I find something interesting about Shandong Xinhua Pharmaceutical Co Ltd.

Quick analysis of Shandong Xinhua Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Shandong Xinhua Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.04
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥7.08
Expected worth in 1 year
¥7.66
How sure are you?
95.7%

+ What do you gain per year?

Total Gains per Share
¥0.84
Return On Investment
5.4%

For what price can you sell your share?

Current Price per Share
¥15.70
Expected price per share
¥13.45 - ¥18.29
How sure are you?
50%

1. Valuation of Shandong Xinhua Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥15.70

Intrinsic Value Per Share

¥10.96 - ¥13.10

Total Value Per Share

¥18.03 - ¥20.18

2. Growth of Shandong Xinhua Pharmaceutical Co Ltd (5 min.)




Is Shandong Xinhua Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$659m$574.8m$66m10.3%

How much money is Shandong Xinhua Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$17.1m$14.1m$2.9m17.2%
Net Profit Margin6.2%5.5%--

How much money comes from the company's main activities?

3. Financial Health of Shandong Xinhua Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Shandong Xinhua Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Shandong Xinhua Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Shandong Xinhua Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Shandong Xinhua Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Shandong Xinhua Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Shandong Xinhua Pharmaceutical Co Ltd is ¥15.70. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Shandong Xinhua Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Shandong Xinhua Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥7.08. Based on the TTM, the Book Value Change Per Share is ¥0.15 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.17 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.07 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Shandong Xinhua Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.020.1%0.030.2%0.020.1%0.020.1%0.020.1%
Usd Book Value Change Per Share0.020.1%0.020.1%0.020.1%0.020.1%0.040.3%
Usd Dividend Per Share0.000.0%0.010.1%0.010.1%0.010.0%0.010.0%
Usd Total Gains Per Share0.020.1%0.030.2%0.030.2%0.030.2%0.050.3%
Usd Price Per Share2.81-2.99-2.95-1.92-1.80-
Price to Earnings Ratio32.88-29.66-33.13-23.04-22.54-
Price-to-Total Gains Ratio162.66-713.38-196.51-243.96-217.09-
Price to Book Ratio2.88-3.15-3.42-2.33-2.24-
Price-to-Total Gains Ratio162.66-713.38-196.51-243.96-217.09-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.1666
Number of shares461
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.020.02
Usd Total Gains Per Share0.030.03
Gains per Quarter (461 shares)13.4111.81
Gains per Year (461 shares)53.6547.23
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1173744143337
2337498296684
3501111524398131
46614820658131178
58318526072164225
610022231486197272
7116259368101230319
8133296422115263366
9149334476130295413
10166371530144328460

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%23.00.00.0100.0%23.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%10.02.00.083.3%17.03.00.085.0%20.03.00.087.0%20.03.00.087.0%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%23.00.00.0100.0%23.00.00.0100.0%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%19.01.00.095.0%22.01.00.095.7%22.01.00.095.7%

Fundamentals of Shandong Xinhua Pharmaceutical Co Ltd

About Shandong Xinhua Pharmaceutical Co Ltd

Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People's Republic of China, the Americas, Europe, and internationally. The company offers antipyretic and analgesic drugs; cardiovascular and cerebrovascular drugs; anti-infective drugs and central nervous drugs; and other drugs. It engages in the development of real estate business. Shandong Xinhua Pharmaceutical Company Limited was founded in 1943 and is based in Zibo, the People's Republic of China.

Fundamental data was last updated by Penke on 2024-04-23 05:10:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Shandong Xinhua Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Shandong Xinhua Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Shandong Xinhua Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 6.5% means that ¥0.07 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Shandong Xinhua Pharmaceutical Co Ltd:

  • The MRQ is 6.5%. The company is making a profit. +1
  • The TTM is 6.2%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ6.5%TTM6.2%+0.3%
TTM6.2%YOY5.5%+0.7%
TTM6.2%5Y5.6%+0.6%
5Y5.6%10Y5.5%+0.1%
1.1.2. Return on Assets

Shows how efficient Shandong Xinhua Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Shandong Xinhua Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.3% Return on Assets means that Shandong Xinhua Pharmaceutical Co Ltd generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Shandong Xinhua Pharmaceutical Co Ltd:

  • The MRQ is 1.3%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.5%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.3%TTM1.5%-0.3%
TTM1.5%YOY1.3%+0.3%
TTM1.5%5Y1.3%+0.3%
5Y1.3%10Y1.3%+0.0%
1.1.3. Return on Equity

Shows how efficient Shandong Xinhua Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Shandong Xinhua Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.3% Return on Equity means Shandong Xinhua Pharmaceutical Co Ltd generated ¥0.02 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Shandong Xinhua Pharmaceutical Co Ltd:

  • The MRQ is 2.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.8%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.3%TTM2.8%-0.5%
TTM2.8%YOY2.6%+0.2%
TTM2.8%5Y2.6%+0.2%
5Y2.6%10Y2.6%+0.0%

1.2. Operating Efficiency of Shandong Xinhua Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Shandong Xinhua Pharmaceutical Co Ltd is operating .

  • Measures how much profit Shandong Xinhua Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Shandong Xinhua Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Shandong Xinhua Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM5.4%-5.4%
TTM5.4%YOY4.8%+0.6%
TTM5.4%5Y6.4%-1.0%
5Y6.4%10Y6.5%-0.1%
1.2.2. Operating Ratio

Measures how efficient Shandong Xinhua Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.61 means that the operating costs are ¥1.61 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Shandong Xinhua Pharmaceutical Co Ltd:

  • The MRQ is 1.608. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.630. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.608TTM1.630-0.022
TTM1.630YOY1.657-0.027
TTM1.6305Y1.624+0.007
5Y1.62410Y1.626-0.002

1.3. Liquidity of Shandong Xinhua Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Shandong Xinhua Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.33 means the company has ¥1.33 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Shandong Xinhua Pharmaceutical Co Ltd:

  • The MRQ is 1.333. The company is just able to pay all its short-term debts.
  • The TTM is 1.372. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.333TTM1.372-0.039
TTM1.372YOY1.022+0.350
TTM1.3725Y1.155+0.218
5Y1.15510Y1.140+0.015
1.3.2. Quick Ratio

Measures if Shandong Xinhua Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Shandong Xinhua Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.28 means the company can pay off ¥0.28 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Shandong Xinhua Pharmaceutical Co Ltd:

  • The MRQ is 0.282. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.455. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.282TTM0.455-0.174
TTM0.455YOY0.320+0.136
TTM0.4555Y0.342+0.113
5Y0.34210Y0.334+0.008

1.4. Solvency of Shandong Xinhua Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Shandong Xinhua Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Shandong Xinhua Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.42 means that Shandong Xinhua Pharmaceutical Co Ltd assets are financed with 42.4% credit (debt) and the remaining percentage (100% - 42.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Shandong Xinhua Pharmaceutical Co Ltd:

  • The MRQ is 0.424. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.424. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.424TTM0.4240.000
TTM0.424YOY0.481-0.056
TTM0.4245Y0.492-0.067
5Y0.49210Y0.496-0.004
1.4.2. Debt to Equity Ratio

Measures if Shandong Xinhua Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Shandong Xinhua Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 77.1% means that company has ¥0.77 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Shandong Xinhua Pharmaceutical Co Ltd:

  • The MRQ is 0.771. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.774. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.771TTM0.774-0.003
TTM0.774YOY0.975-0.200
TTM0.7745Y1.026-0.252
5Y1.02610Y1.043-0.017

2. Market Valuation of Shandong Xinhua Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Shandong Xinhua Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Shandong Xinhua Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 32.88 means the investor is paying ¥32.88 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Shandong Xinhua Pharmaceutical Co Ltd:

  • The EOD is 25.330. Based on the earnings, the company is overpriced. -1
  • The MRQ is 32.881. Based on the earnings, the company is overpriced. -1
  • The TTM is 29.657. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD25.330MRQ32.881-7.551
MRQ32.881TTM29.657+3.224
TTM29.657YOY33.130-3.473
TTM29.6575Y23.039+6.618
5Y23.03910Y22.536+0.503
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Shandong Xinhua Pharmaceutical Co Ltd:

  • The EOD is 41.059. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 53.298. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is -19.012. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD41.059MRQ53.298-12.239
MRQ53.298TTM-19.012+72.311
TTM-19.012YOY-15.618-3.394
TTM-19.0125Y-1.117-17.895
5Y-1.11710Y0.208-1.325
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Shandong Xinhua Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Shandong Xinhua Pharmaceutical Co Ltd:

  • The EOD is 2.218. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.879. Based on the equity, the company is underpriced. +1
  • The TTM is 3.147. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.218MRQ2.879-0.661
MRQ2.879TTM3.147-0.268
TTM3.147YOY3.416-0.269
TTM3.1475Y2.329+0.818
5Y2.32910Y2.244+0.085
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Shandong Xinhua Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1110.146-24%0.169-35%0.129-14%0.308-64%
Book Value Per Share--7.0796.885+3%6.220+14%5.765+23%5.589+27%
Current Ratio--1.3331.372-3%1.022+30%1.155+15%1.140+17%
Debt To Asset Ratio--0.4240.4240%0.481-12%0.492-14%0.496-15%
Debt To Equity Ratio--0.7710.7740%0.975-21%1.026-25%1.043-26%
Dividend Per Share--0.0150.065-78%0.061-76%0.057-74%0.054-73%
Eps--0.1550.184-16%0.166-7%0.148+5%0.142+9%
Free Cash Flow Per Share--0.096-0.022+123%0.192-50%0.044+115%0.041+135%
Free Cash Flow To Equity Per Share--0.096-0.099+204%0.143-33%0.007+1217%0.009+1000%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--13.099--------
Intrinsic Value_10Y_min--10.956--------
Intrinsic Value_1Y_max--0.388--------
Intrinsic Value_1Y_min--0.381--------
Intrinsic Value_3Y_max--1.871--------
Intrinsic Value_3Y_min--1.772--------
Intrinsic Value_5Y_max--4.203--------
Intrinsic Value_5Y_min--3.841--------
Market Cap7652305600.000-80%13750036177.30014590217145.138-6%14309934011.950-4%9100627196.497+51%8510221582.919+62%
Net Profit Margin--0.0650.062+5%0.055+19%0.056+17%0.055+19%
Operating Margin---0.054-100%0.048-100%0.064-100%0.065-100%
Operating Ratio--1.6081.630-1%1.657-3%1.624-1%1.626-1%
Pb Ratio2.218-30%2.8793.147-9%3.416-16%2.329+24%2.244+28%
Pe Ratio25.330-30%32.88129.657+11%33.130-1%23.039+43%22.536+46%
Price Per Share15.700-30%20.38021.633-6%21.370-5%13.924+46%13.067+56%
Price To Free Cash Flow Ratio41.059-30%53.298-19.012+136%-15.618+129%-1.117+102%0.208+25527%
Price To Total Gains Ratio125.310-30%162.663713.385-77%196.513-17%243.957-33%217.089-25%
Quick Ratio--0.2820.455-38%0.320-12%0.342-18%0.334-16%
Return On Assets--0.0130.015-18%0.013-2%0.013-2%0.013+1%
Return On Equity--0.0230.028-18%0.026-12%0.026-13%0.026-12%
Total Gains Per Share--0.1250.211-41%0.230-46%0.186-32%0.362-65%
Usd Book Value--659053953.573640895193.278+3%574821469.366+15%513780282.869+28%496229902.001+33%
Usd Book Value Change Per Share--0.0150.020-24%0.023-35%0.018-14%0.042-64%
Usd Book Value Per Share--0.9770.950+3%0.858+14%0.796+23%0.771+27%
Usd Dividend Per Share--0.0020.009-78%0.008-76%0.008-74%0.007-73%
Usd Eps--0.0210.025-16%0.023-7%0.020+5%0.020+9%
Usd Free Cash Flow--8900369.123-2064977.074+123%17715161.090-50%4038407.198+120%3691187.943+141%
Usd Free Cash Flow Per Share--0.013-0.003+123%0.026-50%0.006+115%0.006+135%
Usd Free Cash Flow To Equity Per Share--0.013-0.014+204%0.020-33%0.001+1217%0.001+1000%
Usd Market Cap1056018172.800-80%1897504992.4672013449966.029-6%1974770893.649-4%1255886553.117+51%1174410578.443+62%
Usd Price Per Share2.167-30%2.8122.985-6%2.949-5%1.922+46%1.803+56%
Usd Profit--14427048.31017129670.943-16%14186182.082+2%12979453.408+11%12385920.408+16%
Usd Revenue--221256762.993279479142.403-21%258853055.022-15%233051066.628-5%225396223.689-2%
Usd Total Gains Per Share--0.0170.029-41%0.032-46%0.026-32%0.050-65%
 EOD+4 -4MRQTTM+14 -21YOY+12 -235Y+19 -1610Y+20 -15

3.2. Fundamental Score

Let's check the fundamental score of Shandong Xinhua Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1525.330
Price to Book Ratio (EOD)Between0-12.218
Net Profit Margin (MRQ)Greater than00.065
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.282
Current Ratio (MRQ)Greater than11.333
Debt to Asset Ratio (MRQ)Less than10.424
Debt to Equity Ratio (MRQ)Less than10.771
Return on Equity (MRQ)Greater than0.150.023
Return on Assets (MRQ)Greater than0.050.013
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Shandong Xinhua Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.102
Ma 20Greater thanMa 5015.902
Ma 50Greater thanMa 10016.683
Ma 100Greater thanMa 20018.107
OpenGreater thanClose15.480
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Selling General Administrative  54,007425,069479,076-384,87494,203335,121429,324-464,922-35,598



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets8,286,166
Total Liabilities3,510,413
Total Stockholder Equity4,553,104
 As reported
Total Liabilities 3,510,413
Total Stockholder Equity+ 4,553,104
Total Assets = 8,286,166

Assets

Total Assets8,286,166
Total Current Assets3,314,334
Long-term Assets4,971,833
Total Current Assets
Cash And Cash Equivalents 918,334
Net Receivables 699,878
Inventory 1,312,984
Other Current Assets 89,147
Total Current Assets  (as reported)3,314,334
Total Current Assets  (calculated)3,020,343
+/- 293,991
Long-term Assets
Property Plant Equipment 4,060,814
Intangible Assets 494,937
Long-term Assets Other 102,863
Long-term Assets  (as reported)4,971,833
Long-term Assets  (calculated)4,658,614
+/- 313,218

Liabilities & Shareholders' Equity

Total Current Liabilities2,486,000
Long-term Liabilities1,024,413
Total Stockholder Equity4,553,104
Total Current Liabilities
Short Long Term Debt 283,959
Accounts payable 1,177,843
Other Current Liabilities 22,931
Total Current Liabilities  (as reported)2,486,000
Total Current Liabilities  (calculated)1,484,733
+/- 1,001,268
Long-term Liabilities
Long term Debt 799,400
Capital Lease Obligations Min Short Term Debt1,579
Long-term Liabilities Other 3,562
Long-term Liabilities  (as reported)1,024,413
Long-term Liabilities  (calculated)804,540
+/- 219,872
Total Stockholder Equity
Retained Earnings 2,305,439
Total Stockholder Equity (as reported)4,553,104
Total Stockholder Equity (calculated)2,305,439
+/- 2,247,665
Other
Capital Stock674,683
Common Stock Shares Outstanding 674,683
Net Debt 165,024
Net Invested Capital 5,636,463
Net Working Capital 828,333
Property Plant and Equipment Gross 4,060,814



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
> Total Assets 
5,671,642
5,742,323
5,916,156
6,040,069
6,096,275
6,049,248
6,436,025
7,044,298
6,795,794
6,695,857
7,092,952
7,279,400
7,271,501
7,189,408
7,332,034
7,674,087
7,946,216
8,194,604
8,265,131
7,976,650
8,075,585
7,921,817
8,286,166
8,286,1667,921,8178,075,5857,976,6508,265,1318,194,6047,946,2167,674,0877,332,0347,189,4087,271,5017,279,4007,092,9526,695,8576,795,7947,044,2986,436,0256,049,2486,096,2756,040,0695,916,1565,742,3235,671,642
   > Total Current Assets 
2,303,286
2,299,425
2,349,165
2,329,699
2,303,166
2,154,327
2,428,387
3,094,024
2,810,806
2,587,306
2,686,871
2,851,445
2,848,432
2,694,392
2,753,958
3,055,125
3,287,926
3,464,395
3,456,959
3,136,311
3,235,189
3,026,216
3,314,334
3,314,3343,026,2163,235,1893,136,3113,456,9593,464,3953,287,9263,055,1252,753,9582,694,3922,848,4322,851,4452,686,8712,587,3062,810,8063,094,0242,428,3872,154,3272,303,1662,329,6992,349,1652,299,4252,303,286
       Cash And Cash Equivalents 
904,876
838,859
778,423
648,311
661,965
628,762
690,470
1,335,553
1,114,374
949,279
855,771
913,617
948,752
817,890
744,662
952,052
1,110,710
1,212,767
1,158,742
863,701
979,173
824,282
918,334
918,334824,282979,173863,7011,158,7421,212,7671,110,710952,052744,662817,890948,752913,617855,771949,2791,114,3741,335,553690,470628,762661,965648,311778,423838,859904,876
       Net Receivables 
652,543
724,893
513,532
646,180
594,976
549,632
474,908
851,234
782,407
694,478
543,711
894,491
971,176
841,186
887,871
1,136,946
1,074,590
1,187,285
761,259
1,209,136
1,175,857
1,093,760
699,878
699,8781,093,7601,175,8571,209,136761,2591,187,2851,074,5901,136,946887,871841,186971,176894,491543,711694,478782,407851,234474,908549,632594,976646,180513,532724,893652,543
       Inventory 
670,638
657,272
951,723
793,252
782,749
753,606
1,130,343
810,173
788,306
818,818
1,124,364
914,867
844,467
901,656
1,027,540
846,589
1,035,132
970,173
1,211,987
969,460
1,010,804
970,748
1,312,984
1,312,984970,7481,010,804969,4601,211,987970,1731,035,132846,5891,027,540901,656844,467914,8671,124,364818,818788,306810,1731,130,343753,606782,749793,252951,723657,272670,638
       Other Current Assets 
73,807
78,401
100,346
31,528
34,839
29,383
128,230
97,065
114,091
124,732
155,876
128,469
78,785
133,660
93,876
119,538
67,494
94,170
102,948
94,014
69,331
137,427
89,147
89,147137,42769,33194,014102,94894,17067,494119,53893,876133,66078,785128,469155,876124,732114,09197,065128,23029,38334,83931,528100,34678,40173,807
   > Long-term Assets 
0
0
0
3,710,370
3,793,109
3,894,921
4,007,638
3,950,274
3,984,988
4,108,551
4,406,081
4,427,955
4,423,069
4,495,016
4,578,075
4,618,962
4,658,290
4,730,209
4,808,172
4,840,339
4,840,395
4,895,601
4,971,833
4,971,8334,895,6014,840,3954,840,3394,808,1724,730,2094,658,2904,618,9624,578,0754,495,0164,423,0694,427,9554,406,0814,108,5513,984,9883,950,2744,007,6383,894,9213,793,1093,710,370000
       Property Plant Equipment 
2,744,979
2,800,148
2,884,364
2,936,609
3,011,397
3,075,982
3,200,977
3,209,612
3,251,869
3,362,468
3,538,852
3,564,662
3,603,530
3,697,596
3,765,724
3,822,232
3,856,466
3,944,631
4,000,465
3,995,824
3,982,792
3,991,290
4,060,814
4,060,8143,991,2903,982,7923,995,8244,000,4653,944,6313,856,4663,822,2323,765,7243,697,5963,603,5303,564,6623,538,8523,362,4683,251,8693,209,6123,200,9773,075,9823,011,3972,936,6092,884,3642,800,1482,744,979
       Long Term Investments 
206,428
225,550
209,334
304,575
316,120
299,740
296,248
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000296,248299,740316,120304,575209,334225,550206,428
       Intangible Assets 
319,921
317,721
332,704
331,561
3,723
410,398
411,594
415,346
412,882
410,514
449,247
446,187
454,185
450,530
466,451
473,094
480,911
475,203
474,107
467,721
463,365
464,921
494,937
494,937464,921463,365467,721474,107475,203480,911473,094466,451450,530454,185446,187449,247410,514412,882415,346411,594410,3983,723331,561332,704317,721319,921
       Long-term Assets Other 
0
0
0
42,577
3,793,109
2,000
4,007,638
2,000
0
3,361,120
15,913
15,928
11,673
11,673
14,226
9,944
3,936
9,657
21,492
44,275
80,531
103,376
102,863
102,863103,37680,53144,27521,4929,6573,9369,94414,22611,67311,67315,92815,9133,361,12002,0004,007,6382,0003,793,10942,577000
> Total Liabilities 
2,994,520
2,971,925
3,119,603
3,133,317
3,161,684
3,030,939
3,325,495
3,878,547
3,642,977
3,452,026
3,701,662
3,744,102
3,747,287
3,601,189
3,680,889
3,627,144
3,874,926
4,001,251
3,915,226
3,427,018
3,525,406
3,220,709
3,510,413
3,510,4133,220,7093,525,4063,427,0183,915,2264,001,2513,874,9263,627,1443,680,8893,601,1893,747,2873,744,1023,701,6623,452,0263,642,9773,878,5473,325,4953,030,9393,161,6843,133,3173,119,6032,971,9252,994,520
   > Total Current Liabilities 
2,118,438
2,214,053
2,360,045
2,351,982
2,264,546
2,112,565
2,485,514
2,481,573
2,291,818
2,116,568
2,381,039
2,150,163
2,507,368
2,400,801
2,501,880
3,322,627
3,286,848
3,221,776
3,158,486
2,136,890
2,482,219
2,185,532
2,486,000
2,486,0002,185,5322,482,2192,136,8903,158,4863,221,7763,286,8483,322,6272,501,8802,400,8012,507,3682,150,1632,381,0392,116,5682,291,8182,481,5732,485,5142,112,5652,264,5462,351,9822,360,0452,214,0532,118,438
       Short-term Debt 
376,000
574,826
526,000
200,000
340,000
540,000
540,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000540,000540,000340,000200,000526,000574,826376,000
       Short Long Term Debt 
376,000
574,826
526,000
200,000
340,000
540,000
540,000
560,000
230,000
70,000
200,420
308,774
331,074
330,363
269,455
340,025
369,070
382,449
118,023
233,128
243,495
269,316
283,959
283,959269,316243,495233,128118,023382,449369,070340,025269,455330,363331,074308,774200,42070,000230,000560,000540,000540,000340,000200,000526,000574,826376,000
       Accounts payable 
889,668
875,425
889,607
917,603
838,491
762,791
798,512
780,110
682,450
623,943
742,903
875,047
905,554
950,219
1,066,391
1,057,736
1,199,783
1,220,398
1,090,080
1,086,236
1,150,295
969,969
1,177,843
1,177,843969,9691,150,2951,086,2361,090,0801,220,3981,199,7831,057,7361,066,391950,219905,554875,047742,903623,943682,450780,110798,512762,791838,491917,603889,607875,425889,668
       Other Current Liabilities 
480,595
498,706
519,176
769,057
563,539
207,259
685,617
695,446
722,997
831,863
934,742
804,517
714,910
642,118
653,510
586,593
1,283,164
1,565,261
85,810
654,500
601,522
581,333
22,931
22,931581,333601,522654,50085,8101,565,2611,283,164586,593653,510642,118714,910804,517934,742831,863722,997695,446685,617207,259563,539769,057519,176498,706480,595
   > Long-term Liabilities 
0
0
0
781,334
897,139
918,374
839,981
1,396,974
1,351,159
1,335,458
1,320,623
1,593,939
1,239,918
1,200,388
1,179,008
304,516
588,078
779,475
756,741
1,290,128
1,043,187
1,035,178
1,024,413
1,024,4131,035,1781,043,1871,290,128756,741779,475588,078304,5161,179,0081,200,3881,239,9181,593,9391,320,6231,335,4581,351,1591,396,974839,981918,374897,139781,334000
       Capital Lease Obligations 
0
0
0
1,567
1,668
1,311
856
786
460
803
1,763
1,689
1,689
1,804
4,279
3,943
4,246
3,977
2,715
2,112
2,073
1,729
1,579
1,5791,7292,0732,1122,7153,9774,2463,9434,2791,8041,6891,6891,7638034607868561,3111,6681,567000
       Long-term Liabilities Other 
0
0
0
557,722
665,910
3,562
3,562
3,562
3,562
3,562
3,562
3,562
3,562
3,562
3,562
30,763
3,562
3,562
3,562
3,562
3,562
3,562
3,562
3,5623,5623,5623,5623,5623,5623,56230,7633,5623,5623,5623,5623,5623,5623,5623,5623,5623,562665,910557,722000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
11,916
11,300
10,684
10,067
10,541
9,870
9,199
8,528
8,608
7,896
7,224
15,072
0
015,0727,2247,8968,6088,5289,1999,87010,54110,06710,68411,30011,9160000000000
> Total Stockholder Equity
2,535,826
2,622,896
2,687,248
2,791,190
2,813,417
2,893,341
2,969,028
3,016,471
3,023,506
3,110,751
3,223,794
3,359,487
3,330,193
3,406,442
3,467,942
3,848,478
3,876,385
3,972,803
4,126,460
4,323,962
4,330,815
4,479,375
4,553,104
4,553,1044,479,3754,330,8154,323,9624,126,4603,972,8033,876,3853,848,4783,467,9423,406,4423,330,1933,359,4873,223,7943,110,7513,023,5063,016,4712,969,0282,893,3412,813,4172,791,1902,687,2482,622,8962,535,826
   Common Stock
478,353
621,859
621,859
621,859
621,859
621,859
621,859
621,859
621,859
621,859
621,859
627,367
627,367
627,367
627,367
669,627
669,627
669,627
669,627
673,888
674,683
674,683
0
0674,683674,683673,888669,627669,627669,627669,627627,367627,367627,367627,367621,859621,859621,859621,859621,859621,859621,859621,859621,859621,859478,353
   Retained Earnings 
1,173,281
1,243,248
1,299,928
1,119,263
1,129,106
1,217,140
1,529,581
1,615,867
1,626,155
1,699,909
1,779,817
1,880,093
1,885,794
1,971,048
2,034,260
2,142,764
2,128,206
2,227,260
2,345,010
2,496,614
2,479,881
2,602,042
2,305,439
2,305,4392,602,0422,479,8812,496,6142,345,0102,227,2602,128,2062,142,7642,034,2601,971,0481,885,7941,880,0931,779,8171,699,9091,626,1551,615,8671,529,5811,217,1401,129,1061,119,2631,299,9281,243,2481,173,281
   Capital Surplus 00000000000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
155,741
172,844
142,645
169,051
179,343
169,143
183,445
142,510
139,394
150,793
177,211
179,795
141,615
131,504
128,373
115,449
120,332
106,097
113,679
122,634
128,197
140,915
0
0140,915128,197122,634113,679106,097120,332115,449128,373131,504141,615179,795177,211150,793139,394142,510183,445169,143179,343169,051142,645172,844155,741



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue8,100,845
Cost of Revenue-5,709,142
Gross Profit2,391,7022,391,702
 
Operating Income (+$)
Gross Profit2,391,702
Operating Expense-7,488,651
Operating Income612,193-5,096,949
 
Operating Expense (+$)
Research Development419,240
Selling General Administrative967,005
Selling And Marketing Expenses0
Operating Expense7,488,6511,386,245
 
Net Interest Income (+$)
Interest Income12,300
Interest Expense-41,149
Other Finance Cost-2,924
Net Interest Income-31,772
 
Pretax Income (+$)
Operating Income612,193
Net Interest Income-31,772
Other Non-Operating Income Expenses0
Income Before Tax (EBT)532,686612,193
EBIT - interestExpense = -41,149
496,512
537,661
Interest Expense41,149
Earnings Before Interest and Taxes (EBIT)0573,834
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax532,686
Tax Provision-26,579
Net Income From Continuing Ops506,107506,107
Net Income496,512
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net031,772
 

Technical Analysis of Shandong Xinhua Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Shandong Xinhua Pharmaceutical Co Ltd. The general trend of Shandong Xinhua Pharmaceutical Co Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Shandong Xinhua Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Shandong Xinhua Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 16.83 < 18.15 < 18.29.

The bearish price targets are: 14.99 > 13.45.

Tweet this
Shandong Xinhua Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Shandong Xinhua Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shandong Xinhua Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Shandong Xinhua Pharmaceutical Co Ltd. The current macd is -0.41848058.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Shandong Xinhua Pharmaceutical Co Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Shandong Xinhua Pharmaceutical Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Shandong Xinhua Pharmaceutical Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Shandong Xinhua Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartShandong Xinhua Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Shandong Xinhua Pharmaceutical Co Ltd. The current adx is 30.65.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Shandong Xinhua Pharmaceutical Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Shandong Xinhua Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Shandong Xinhua Pharmaceutical Co Ltd. The current sar is 15.01.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Shandong Xinhua Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Shandong Xinhua Pharmaceutical Co Ltd. The current rsi is 43.10. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Shandong Xinhua Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartShandong Xinhua Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Shandong Xinhua Pharmaceutical Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Shandong Xinhua Pharmaceutical Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Shandong Xinhua Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartShandong Xinhua Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Shandong Xinhua Pharmaceutical Co Ltd. The current cci is -40.62738753.

Shandong Xinhua Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartShandong Xinhua Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Shandong Xinhua Pharmaceutical Co Ltd. The current cmo is -7.15339301.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Shandong Xinhua Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartShandong Xinhua Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Shandong Xinhua Pharmaceutical Co Ltd. The current willr is -51.36986301.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Shandong Xinhua Pharmaceutical Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Shandong Xinhua Pharmaceutical Co Ltd Daily Williams %R ChartShandong Xinhua Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Shandong Xinhua Pharmaceutical Co Ltd.

Shandong Xinhua Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Shandong Xinhua Pharmaceutical Co Ltd. The current atr is 0.45564257.

Shandong Xinhua Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartShandong Xinhua Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Shandong Xinhua Pharmaceutical Co Ltd. The current obv is 984,026,105.

Shandong Xinhua Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartShandong Xinhua Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Shandong Xinhua Pharmaceutical Co Ltd. The current mfi is 54.69.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Shandong Xinhua Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartShandong Xinhua Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Shandong Xinhua Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-07BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.

6.3. Candlestick Patterns

Shandong Xinhua Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Shandong Xinhua Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.102
Ma 20Greater thanMa 5015.902
Ma 50Greater thanMa 10016.683
Ma 100Greater thanMa 20018.107
OpenGreater thanClose15.480
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Shandong Xinhua Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Shandong Xinhua Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Shandong Xinhua Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Shandong Xinhua Pharmaceutical Co Ltd

I send you an email if I find something interesting about Shandong Xinhua Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Shandong Xinhua Pharmaceutical Co Ltd.

Receive notifications about Shandong Xinhua Pharmaceutical Co Ltd in your mailbox!